{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:22:09Z","timestamp":1794666129441,"version":"4.9.1"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The authors reported a 73-year-old woman with end-stage renal disease who underwent artificial hip replacement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Clinicians monitored tranexamic acid serum levels along with the incidence of central nervous system symptoms and hemodialysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Intravenous tranexamic acid was administered thrice 30 minutes before the surgery, and at 5 hours (2 hours after surgery) and 16 hours (13 hours after surgery) thrice after the first dosing (surgical time: 150 minutes). Although no seizure or its related symptoms were observed before the first hemodialysis, the involuntary movements appeared at the start of hemodialysis. High tranexamic acid serum levels (81.5\u2013116.3 \u03bcg\/mL) were maintained for 25 hours from the initial dosing. The seizure and its related symptoms rapidly disappeared with the single administration of diazepam immediately after the seizures. Tranexamic acid was discontinued after seizures, and the patient underwent hemodialysis at 49, 97, and 145 hours after the first dosing. Serum levels at 45, 120, and 168 hours after first dosing were 19.2, 10.9, and 8.1 \u03bcg\/mL, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Continuous exposure to high serum levels of tranexamic acid may cause seizures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001455","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:00:07Z","timestamp":1783720807000},"page":"417-420","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Serum-Level Profile of Tranexamic Acid and Development of Seizures in a Patient With End-Stage Renal Disease After Receiving Artificial Hip Replacement"],"prefix":"10.1097","volume":"48","author":[{"given":"Daiki","family":"Tsunashima","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Shinshu University Hospital, Matsumoto, Nagano, Japan;"},{"name":"Department of Clinical Pharmacology and Therapeutics, Shinshu University Graduate School of Medicine, Matsumoto, Nagano, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Sakaue","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Shinshu University Hospital, Matsumoto, Nagano, Japan;"},{"name":"Department of Clinical Pharmacology and Therapeutics, Shinshu University Graduate School of Medicine, Matsumoto, Nagano, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Shinshu University Hospital, Matsumoto, Nagano, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Shimodaira","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Shinshu University School of Medicine, Matsumoto, Nagano, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7447-3789","authenticated-orcid":false,"given":"Takafumi","family":"Naito","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Shinshu University Hospital, Matsumoto, Nagano, Japan;"},{"name":"Department of Clinical Pharmacology and Therapeutics, Shinshu University Graduate School of Medicine, Matsumoto, Nagano, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"R2-20261114","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3805\/eands.16.12","article-title":"Tranexamic acid-induced involuntary movements and convulsions in patients undergoing cardiac and thoracic aortic surgery using cardiopulmonary bypass","volume":"16","author":"Shimmura","year":"2024","journal-title":"Epilepsy Seizure"},{"key":"R3-20261114","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4103\/1319-2442.124529","article-title":"Tranexamic acid overdosage-induced generalized seizure in renal failure","volume":"25","author":"Bhat","year":"2014","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R4-20261114","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1051\/ject\/201648137","article-title":"Seizures following cardiopulmonary bypass","volume":"48","author":"Brouwer","year":"2016","journal-title":"J Extra Corpor Technol"},{"key":"R5-20261114","doi-asserted-by":"crossref","first-page":"e01676","DOI":"10.1213\/XAA.0000000000001676","article-title":"Long duration of action of tranexamic acid after cardiac surgery in a hemodialysis patient: a case report","volume":"17","author":"Yoshii","year":"2023","journal-title":"A A Pract"},{"key":"R6-20261114","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.clinbiochem.2020.10.010","article-title":"Analysis of serum tranexamic acid in patients undergoing open heart surgery","volume":"87","author":"Fosko","year":"2021","journal-title":"Clin Biochem"},{"key":"R7-20261114","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.bja.2021.10.054","article-title":"Pharmacokinetics of tranexamic acid after intravenous, intramuscular, and oral routes: a prospective, randomised, crossover trial in healthy volunteers","volume":"128","author":"Grassin-Delyle","year":"2022","journal-title":"Br J Anaesth"},{"key":"R9-20261114","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.24558","article-title":"Tranexamic acid-associated seizures: causes and treatment","volume":"79","author":"Lecker","year":"2016","journal-title":"Ann Neurol"},{"key":"R10-20261114","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13256-023-03768-6","article-title":"Accidental intrathecal injection of tranexamic acid: a case report","volume":"17","author":"Harby","year":"2023","journal-title":"J Med Case Rep"},{"key":"R11-20261114","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/ndt\/gfg117","article-title":"Tranexamic acid is beneficial as adjunctive therapy in treating major upper gastrointestinal bleeding in dialysis patients","volume":"18","author":"Sabovic","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R12-20261114","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00255578","article-title":"Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases","volume":"6","author":"Andersson","year":"1978","journal-title":"Urol Res"},{"key":"R13-20261114","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/08971900251326735","article-title":"Seizures associated with high-dose cefazolin in a patient with renal dysfunction: a case report","volume":"38","author":"Kingra","year":"2025","journal-title":"J Pharm Pract"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:00:12Z","timestamp":1794664812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001455","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"2025-10-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}